Replies to post #691238 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

During Phase 1, the MHRA reviews the MAA submission to ensure that all required documentation and data are provided. This phase focuses on the administrative and procedural aspects of the application, such as reviewing application forms, data on the medicine's quality, non-clinical data, and details of the proposed labeling and packaging. Inspections by the MHRA are not typically conducted during Phase 1. —ChatGPT